rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
21
|
pubmed:dateCreated |
2005-10-25
|
pubmed:abstractText |
Epitopes of a foot-and-mouth disease virus (FMDV) capsid protein VP1 complex and a chimera of 6xHis-tagged cholera toxin B subunit (hCTB) were expressed in Hansenula polymorpha and used together as a mucosal vaccine. Antibody and cytokine responses to VP1-hCTB vaccine and protection against FMDV were evaluated by ELISA and a virus challenge test in mice, respectively. VP1-hCTB directly enhanced the expression of interleukin-5 (IL-5) both in serum and supernatants of cultured spleen cells. After challenging suckling mice with 10(5) FMDV (=50% lethal dosage per mouse) a greater protection was seen after intraperitoneal and intranasal vaccinations than after oral vaccination. In swine immunized with VP1-hCTB, immune responses were achieved after three administrations, and the vaccine protected swine (80%) when challenged with 10(6.5) FMDV (=50% infectious dosage per swine). These results demonstrated the possibility of using CTB as a mucosal adjuvant to elicit protective immune responses against FMDV.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adjuvants, Immunologic,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Viral,
http://linkedlifedata.com/resource/pubmed/chemical/Capsid Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Cholera Toxin,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-5,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Fusion Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/VP1 protein, Foot-and-mouth...,
http://linkedlifedata.com/resource/pubmed/chemical/Viral Vaccines
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0141-5492
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1669-74
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16247672-Adjuvants, Immunologic,
pubmed-meshheading:16247672-Animals,
pubmed-meshheading:16247672-Antibodies, Viral,
pubmed-meshheading:16247672-Capsid Proteins,
pubmed-meshheading:16247672-Cells, Cultured,
pubmed-meshheading:16247672-Cholera Toxin,
pubmed-meshheading:16247672-Female,
pubmed-meshheading:16247672-Foot-and-Mouth Disease,
pubmed-meshheading:16247672-Foot-and-Mouth Disease Virus,
pubmed-meshheading:16247672-Immunity, Mucosal,
pubmed-meshheading:16247672-Interleukin-5,
pubmed-meshheading:16247672-Mice,
pubmed-meshheading:16247672-Mice, Inbred BALB C,
pubmed-meshheading:16247672-Recombinant Fusion Proteins,
pubmed-meshheading:16247672-Spleen,
pubmed-meshheading:16247672-Swine,
pubmed-meshheading:16247672-Viral Vaccines
|
pubmed:year |
2005
|
pubmed:articleTitle |
A novel mucosal vaccine against foot-and-mouth disease virus induces protection in mice and swine.
|
pubmed:affiliation |
Centre for Molecular Microbiology, Institute of Microbiology, Chinese Academy of Sciences, 13# Zhongguancun Beiyitiao, 100080, Beijing, PR China. songhouhui@yahoo.com.cn
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|